CL vs PMCB · P/E 34, rev $20.38B vs $8.6M cap
Colgate-Palmolive Company (CL) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the CL and PMCB stock pages for the full models.
Not investment advice.